Axovant Sciences Ltd (AXGT) Stock News
NASDAQ:AXGT - Nasdaq -
AXGT Latest News, Press Relases and Analysis
68 Biggest Movers From Friday
Gainers Aurora Cannabis Inc. (NYSE: ACB) shares jumped 56.1% to close at $9.79 on Friday after voters in multiple US states voted in favor of legalizing recreational and/or...
Mid-Afternoon Market Update: Rogers Jumps Following Upbeat Q3 Results; Pitney Bowes Shares Plunge
Toward the end of trading Friday, the Dow traded down 1.45% to 26,272.64 while the NASDAQ fell 2.93% to 10,857.97. The S&P also fell, dropping 1.93% to 3,246.08. The U.S. has...
Top Penny Stocks To Buy Under $4; 1 Up 220% In October 2020
4 Penny Stocks Under $4.50 To Watch Right Now
5 Biotech Penny Stocks To Watch With Recent & Upcoming Events
Penny Stocks To Watch Right Now If You Like The Biotechnology Sector
What Are The Best Penny Stocks To Buy Right Now? 5 Names To Know
5 Penny Stocks To Watch As The Market Pushes Higher
Axovant's Gene Therapy Gets Rare Pediatric Disease Status
The FDA bestows a Rare Pediatric Disease status on Axovant's (AXGT) gene therapy candidate AXO-AAV-GM1, which is being developed for the treatment of GM1 gangliosidosis. Stock appreciates.
Axovant Gene Therapies candidate nabs Rare Pediatric Disease tag for nerve cell disorder (NASDAQ:AXGT)
The FDA grants Rare Pediatric Disease designation to Axovant Gene Therapies' (NASDAQ:AXGT) AXO-AAV-GM1, an AAV0-based gene therapy for the GM1 gangliosidosis, a rare inherited disorder characterized by the progressive destruction of nerve cells (neurons) in the brain and spinal cord.Rare Pediatric Disease designation provides for the issuance of a priority review voucher following FDA approval.
Do Options Traders Know Something About Axovant (AXGT) Stock We Don't?
Investors need to pay close attention to Axovant (AXGT) stock based on the movements in the options market lately.